Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts

Natural Product Research

Volumn 24, Issue 3, 2010, Pages 274-285

  Winnicka, Katarzyna ^a   Bielawski, Krzysztof ^a   Bielawska, Anna ^a   Miltyk, Wojciech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Cardiac glycosides; Cytotoxicity; Human fibroblasts

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); CALCIUM; CARDIAC GLYCOSIDE; CASPASE 3; DIGOXIN; MITOGEN ACTIVATED PROTEIN KINASE 3; OUABAIN; PROSCILLARIDIN;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

APOPTOSIS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OUABAIN; PROSCILLARIDIN; SIGNAL TRANSDUCTION;

STROPHANTHUS GRATUS;

EID: 76949103434     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410902991878     Document Type: Article

References (27)

1. Bielawski, K., Winnicka, K., & Bielawska, A. (2006). Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biological & Pharmaceutical Bulletin, 7, 1493-1497.
2. 2+ stores and cell responsiveness. American Journal of Physiology, 264, C1367-C1387.
3. Carmichael, J., Degraff, W., Gazdar, A., Minna, J., & Mitchell, J. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research, 47, 936-942.
4. Chang, L., & Karin, M. (2001). Mammalian MAP kinase signaling cascades. Nature, 410, 37-40.
5. Duke, R.C., & Cohen, J.J. (1992). Morphological and biochemical assays of apoptosis. Current Protocols in Immunology, 17, 1-16.
6. Evans, W. (1996). Trease and Evans' pharmacognosy (pp. 309-316). London:WB Saunders Company.
7. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry, 260, 3440-3450.
8. Hashimoto, S., Jing, Y., Kawazoe, N., Masuda, Y., Nakajo, S., Yoshida, T., et al. (1997). Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Research, 21, 875-883.
9. Haux, J. (1999). Digitoxin is a potential anticancer agent for several types of cancer. Medical Hypotheses, 53, 543-548.
10. Huang, Y.T., Chueh, S.C., Teng, C.M., & Guh, J.H. (2004). Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. Biochemical Pharmacology, 67, 727-733.
11. Isaev, N.K., Stelmashook, E.V., Halle, A., Harms, C., Lautenschlager, M., Weih, M., et al. (2000). Inhibition of Na+/K+-ATPase activity in cultured rat cerebellar granule cells prevents the onset of apoptosis induced by low potassium. Neuroscience Letters, 283, 41-44.
12. Johansson, S., Lindholm, P., Gullbo, J., Larsson, R., Bohlin, L., & Claeson, P. (2001). Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs, 12, 475-483.
13. Kasarov, L.B., & Friedman, H. (1974). Enhanced Na+-K+-activated adenosine triphosphatase activity in transformed fibroblasts. Cancer Research, 34, 1862-1865.
14. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227, 680-685.
15. Martin, S.J., Reutelingsperger, C.P.M., McGahon, A.J., Rader, J.A., & van Schie, R.C. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine, 182, 1545-1556.
16. Masuda, Y., Kawazoe, N., Nakajo, S., Yoshida, T., Kuroiwa, Y., & Nakaya, K. (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Research, 19, 549-556.
17. Orlov, S.N., Thorin-Trescases, N., Kotelevtsev, S.V., Tremblay, J., & Hamet, P. (1999). Inversion of the intracellular Na+/K+ ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. Journal of Biological Chemistry, 274, 16545-16552.
18. Racker, E., Johnson, J.H., & Blackwell, M.T. (1983). The role of ATPase in glycolysis of Ehrlich ascites tumor cells. Journal of Biological Chemistry, 258, 3702-3705.
19. Stenkvist, B. (1999). Is digitalis a therapy for breast carcinoma? Oncology Reports, 6, 493-496.
20. Stenkvist, B., Bengtsson, E., Eklund, G., Eriksson, O., Holmquist, J., Nordin, B., et al. (1980). Evidence of a modifying influence of heart glucosides on the development of breast cancer. Analytical & Quantitative Cytology, 2, 49-54.
21. Trump, B.F., & Berezesky, I.K. (1995). Calcium mediated cell injury and cell death. FASEB Journal, 9, 219-228.
22. Verheye-Dua, F.A., & Bohm, L. (2000). Influence of apoptosis on the enhancement of radiotoxicity by ouabain. Strahlentherapie und Onkologie, 176, 186-191.
23. Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutelingsperger, C. (1995). Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 39-51.
24. Wertz, I.E., & Dixit, V.M. (2000). Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. Journal of Biological Chemistry, 275, 11470-11477.
25. Whitmarsh, A.J., & Davis, R.J. (2000). A central control for cell growth. Nature, 403, 255-256.
26. Winnicka, K., Bielawski, K., Bielawska, A., & Miltyk, W. (2007). Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Archives of Pharmacal Research, 10, 1216-1224.
27. Xie, Z., & Askari, A. (2002). Na+/K+-ATPase as a signal transducer. European Journal of Biochemistry, 269, 2434-2439.